Influenza-Associated Aspergillosis: Nationwide Trends, Predictors and Outcomes From 2005 to 2014
- PMID: 32565269
- DOI: 10.1016/j.chest.2020.06.010
Influenza-Associated Aspergillosis: Nationwide Trends, Predictors and Outcomes From 2005 to 2014
Abstract
Background: Influenza-associated aspergillosis (IAA) has been increasingly reported in the literature in recent years, but contemporary large-scale data on the morbidity and mortality burden of IAA are lacking.
Research question: The goal of this study was to estimate the predictors, associations, and outcomes of IAA in the United States.
Study design and methods: This retrospective cohort study was performed by using the National (Nationwide) Inpatient Sample database from 2005 to 2014 to identify influenza and IAA hospitalizations. Baseline variables and outcomes were compared between influenza hospitalizations without IAA and those with IAA. These variables were then used to perform an adjusted analysis for obtaining predictors and associations of the diagnosis and in-hospital mortality of IAA.
Results: Of the 477,556 hospitalizations identified with the principal diagnosis of influenza, IAA was identified in 823 (0.17%) hospitalizations. The IAA cohort consisted more commonly of 45- to 65-year-olds in urban teaching hospitals with substance abuse. Yearly trends revealed that both influenza and IAA hospitalizations have increased over time, with a peak observed in 2009, the year of the influenza A(H1N1) pandemic. Mortality was higher (20.58% vs 1.36%), average length of stay was longer (17.94 vs 4.05 days), and mean cost per hospitalization was higher ($194,932 vs $24,286) in the IAA cohort compared with the influenza cohort without IAA (P < .005). Solid-organ transplantation, hematologic malignancies, and use of invasive mechanical ventilation were associated with higher odds of IAA, among other factors. Use of invasive mechanical ventilation (adjusted OR, 13.43; P < .005), longer length of stay (adjusted OR, 5.47; P < .005), utilization of extracorporeal membrane oxygenation (adjusted OR, 4.99; P = .014), and the group aged 45 to 64 years (adjusted OR, 3.03; P = .012) were associated with higher in-hospital mortality in the IAA cohort.
Interpretation: Although IAA is a rare complication of influenza hospitalizations, it is associated with increased all-cause mortality, more extended hospital stays, and higher hospital charges compared with influenza without IAA.
Keywords: aspergillus; infection; influenza.
Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Predictors of Hospital-related Outcomes of COVID-19 Infection in Patients With Inflammatory Bowel Disease in the Early Pandemic Phase: A Nationwide Inpatient Database Survey.Inflamm Bowel Dis. 2024 Aug 1;30(8):1334-1344. doi: 10.1093/ibd/izad200. Inflamm Bowel Dis. 2024. PMID: 37725039 Free PMC article.
-
Influenza-associated aspergillosis in critically-ill patients-a retrospective bicentric cohort study.Eur J Clin Microbiol Infect Dis. 2020 Oct;39(10):1915-1923. doi: 10.1007/s10096-020-03923-7. Epub 2020 Jun 3. Eur J Clin Microbiol Infect Dis. 2020. PMID: 32494955 Free PMC article.
-
Incidence and inhospital outcomes of coronavirus disease 2019-associated pulmonary aspergillosis in the United States.Ann Thorac Med. 2024 Jan-Mar;19(1):87-95. doi: 10.4103/atm.atm_190_23. Epub 2024 Jan 25. Ann Thorac Med. 2024. PMID: 38444990 Free PMC article.
-
Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment.Curr Opin Infect Dis. 2018 Dec;31(6):471-480. doi: 10.1097/QCO.0000000000000504. Curr Opin Infect Dis. 2018. PMID: 30299367 Review.
-
A Comparison of COVID-19 and Influenza-Associated Myocarditis: A Nationwide Study in the United States.Curr Probl Cardiol. 2023 Jul;48(7):101680. doi: 10.1016/j.cpcardiol.2023.101680. Epub 2023 Mar 12. Curr Probl Cardiol. 2023. PMID: 36918088 Free PMC article. Review.
Cited by
-
Clinical Uses of Inhaled Antifungals for Invasive Pulmonary Fungal Disease: Promises and Challenges.J Fungi (Basel). 2023 Apr 12;9(4):464. doi: 10.3390/jof9040464. J Fungi (Basel). 2023. PMID: 37108918 Free PMC article. Review.
-
Pulmonary aspergillosis in US Veterans with COVID-19: a nationwide, retrospective cohort study.Antimicrob Steward Healthc Epidemiol. 2025 Jan 30;5(1):e28. doi: 10.1017/ash.2024.476. eCollection 2025. Antimicrob Steward Healthc Epidemiol. 2025. PMID: 39911504 Free PMC article.
-
Epidemiology and Inpatient Outcomes of Invasive Aspergillosis in Patients with Liver Failure and Cirrhosis.J Fungi (Basel). 2025 Apr 23;11(5):334. doi: 10.3390/jof11050334. J Fungi (Basel). 2025. PMID: 40422668 Free PMC article.
-
COVID-19-Associated Pulmonary Mucormycosis.J Fungi (Basel). 2022 Jul 5;8(7):711. doi: 10.3390/jof8070711. J Fungi (Basel). 2022. PMID: 35887466 Free PMC article. Review.
-
Polymicrobial Infections in the Immunocompromised Host: The COVID-19 Realm and Beyond.Med Sci (Basel). 2022 Oct 20;10(4):60. doi: 10.3390/medsci10040060. Med Sci (Basel). 2022. PMID: 36278530 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical